Trial Profile

An 18-months Open Label Phase I Follow-up Study on Patients With Alzheimer's Disease Who Have Completed the AADvac1 Phase I Study 'AXON CO 18700'

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 07 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AADvac 1 (Primary) ; Aluminium hydroxide
Indications Alzheimer's disease
Focus Adverse reactions
Acronyms FUNDAMANT
Sponsors Axon Neuroscience

Most Recent Events

15 Mar 2017 Status changed from active, no longer recruiting to completed.
13 Dec 2016 According to AXON Neuroscience media release, results were presented at the 9th International Conference on Clinical Trials in Alzheimers Disease (CTAD) 2016.
15 Jul 2016 Planned End Date changed from 1 Sep 2017 to 1 Dec 2016.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com